Healthpeak Properties, Inc.
- NYSE
- DOC
- CIK
- 765880
- Industry
- Real Estate Investment Trusts
- Based in
- Denver, Colorado
- Incorporated in
- Maryland
- Fiscal year ends
- December 31
- SEC filer category
- Large accelerated filer
- Employer ID (EIN)
- 33-0091377
- Formerly
- HCP, Inc., Health Care Property Investors Inc
About
AI summary. This paragraph was summarized by AI from the company’s annual report. It may contain mistakes: check it against the source. How it was written
Healthpeak Properties, Inc. is a Maryland corporation and self-administered real estate investment trust that owns, operates, and develops real estate focused on healthcare discovery and delivery in the United States. Organized as an umbrella partnership REIT, it conducts its operations through its operating subsidiary, Healthpeak OP. Its reportable segments are outpatient medical, which includes outpatient medical buildings and hospitals leased to healthcare providers; lab, with properties leased mainly to biotechnology, medical device and pharmaceutical companies and research institutions in markets including San Francisco, Boston and San Diego; and senior housing, consisting of life plan communities and independent and assisted living facilities run by third-party operators through RIDEA structures. Other holdings include loans receivable and a preferred equity investment. The company is headquartered in Denver, Colorado.
Source: the Business section of the company’s 10-K filed Feb 3, 2026.
Key figures
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | $2.82B | $2.70B | $2.18B | $2.06B | $1.90B |
| Net income | $71.3M | $243.1M | $306.0M | $500.4M | $505.5M |
| Diluted EPS | $0.10 | $0.36 | $0.56 | $0.92 | $0.93 |
| Cash from operations | $1.25B | $1.07B | $956.2M | $900.3M | $795.2M |
| Total assets | $20.3B | $19.9B | $15.7B | $15.8B | $15.3B |
| Shareholders’ equity | $7.50B | $8.40B | $6.35B | $6.65B | $6.52B |
From the company’s annual reports to the SEC. Each year links to its report.
Financials 144
- 10-Q Quarterly Report for period ending Sep 30, 2026
- 10-Q Quarterly Report for period ending Jun 30, 2026
- 10-Q Quarterly Report for period ending Mar 31, 2026
- 10-K Annual Report for period ending Dec 31, 2025
- 10-Q Quarterly Report for period ending Sep 30, 2025
- 10-Q Quarterly Report for period ending Jun 30, 2025
- 10-Q Quarterly Report for period ending Mar 31, 2025
- 10-K Annual Report for period ending Dec 31, 2024
- 10-Q Quarterly Report for period ending Sep 30, 2024
- 10-Q Quarterly Report for period ending Jun 30, 2024
News 410
- 8-K Financial results; Regulation FD disclosure
- 8-K Financial results; Regulation FD disclosure
- 8-K Financial results; Regulation FD disclosure
- 8-K Shareholder vote results
- 8-K Material agreement; New debt or obligation
- 8-K Regulation FD disclosure
- 8-K Financial results; Regulation FD disclosure
- 8-K Financial results; Regulation FD disclosure
- 8-K Other events
- 8-K Other events
Ownership 1,489
- 4 Thomas John T (Director): gave 12,350 shares as gifts
- 4 Patadia Ankit B. (EVP and Treasurer): sold 6,115 shares at $20.78 ($127K)
- 144 Patadia Ankit B. (Officer): plans to sell 6,115 shares ($127K)
- 4 Change in insider ownership
- SCHEDULE 13G Major shareholder report (passive investor)
- SCHEDULE 13G/A Major shareholder report (passive investor)
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
Prospectus 361
- 424B5 Prospectus filed pursuant to Rule 424(b)(5)
- FWP Healthpeak OP, LLC: Filing under Securities Act Rules 163/433 of free writing prospectuses
- 424B5 Prospectus filed pursuant to Rule 424(b)(5)
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- 424B5 Prospectus filed pursuant to Rule 424(b)(5)
- 424B5 Prospectus filed pursuant to Rule 424(b)(5)
- FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
- 424B5 Prospectus filed pursuant to Rule 424(b)(5)
- 424B5 Prospectus filed pursuant to Rule 424(b)(5)
- 424B7 Prospectus filed pursuant to Rule 424(b)(7)
Proxies 56
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
Other 99
- ARS Annual report to security holders
- ARS Annual report to security holders
- POSASR Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
- ARS Annual report to security holders
- EFFECT Notice of Effectiveness
- CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
- UPLOAD Letter (PDF)
- ARS Annual report to security holders
- 15-12G Notice of termination of registration of a class of securities under Section 12(g)
- POSASR Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR